Medtronic
Q4 2022 Earnings Call
May 26, 2022, 8:00 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Ryan Weispfenning
Good morning. I'm Ryan Weispfenning, vice president and head of Medtronic investor relations. And I appreciate that you're joining us today for Medtronic's fiscal year 2022 fourth quarter earnings video webcast. Before we go inside to hear prepared remarks, I'll share a few details about today's webcast.
Joining me are Geoff Martha, Medtronic's chairman and chief executive officer and Karen Parkhill, Medtronic's chief financial officer. Geoff and Karen will provide comments on the results of our fourth quarter and fiscal year 2022, which ended on April 29th, 2022, and our outlook for fiscal year '23. After our prepared remarks, our portfolio executive VPs will join us and we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour.
Earlier this morning, we issued a press release containing our financial statements, and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com. During today's program, many of the statements we make may be considered forward-looking statements and actual results may differ materially from those projected in any forward-looking statements.
Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC. And we do not undertake to update any forward-looking statements. Unless we say otherwise all comparisons are on a year-over-year basis. And revenue comparisons are made on an organic basis, which this quarter includes only adjustments for foreign currency as there were no acquisitions or divestitures made in the last four quarters that had a significant impact on total company or individual segment quarterly revenue growth.
References to sequential revenue changes compared to the third quarter of fiscal '22 and are made on an as reported basis. And all references to share gains or losses refer to revenue share in the first calendar quarter of 2022 compared to the first calendar quarter of 2021, unless otherwise stated. Reconciliations of all non-GAAP financial measures can be found in our earnings press release or on our website at investorrelations.medtronic.com. And finally, our EPS guidance does not include any charges or gains that would be reported as non-GAAP adjustments to earnings during the fiscal year.